A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin
Clinical trial NCT03891901 · COMPLETED
Trial details
- NCT number
- NCT03891901
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2022-08-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.